{"gene":"TEFM","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2011,"finding":"TEFM is required for mitochondrial transcription elongation in human cells; RNAi knockdown causes respiratory incompetence and loss of promoter-distal mitochondrial transcripts from both H- and L-strands. Affinity purification from mitochondria shows TEFM forms a complex with POLRMT (mitochondrial RNA polymerase), mitochondrial transcripts, PTCD3, and DHX30; after RNase treatment only POLRMT remains associated with TEFM. TEFM interacts with the catalytic region of POLRMT (defined by deletion mutants). In vitro, TEFM enhances POLRMT processivity on ss- and dsDNA templates. TEFM contains two HhH motifs and an RNase H fold, similar to nuclear elongation factor Spt6. TEFM forms foci coincident with newly synthesized mitochondrial RNA in cultured cells.","method":"RNAi knockdown with respiratory phenotype readout; affinity purification/Co-IP from mitochondria; RNase treatment to define RNA-dependent vs. direct interactions; deletion mutagenesis to map POLRMT interaction; in vitro transcription processivity assay; live-cell imaging of foci","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (in vitro assay, Co-IP, deletion mutagenesis, live imaging, RNAi phenotype) in a single rigorous study establishing the core mechanism","pmids":["21278163"],"is_preprint":false},{"year":2015,"finding":"Recombinant TEFM strongly stimulates POLRMT processivity in a fully reconstituted in vitro mitochondrial transcription system, dramatically increasing formation of longer transcripts. TEFM abolishes premature transcription termination at conserved sequence block II (CSB II), a site linked to replication primer formation. TEFM also substantially increases POLRMT affinity for an elongation-like DNA:RNA template. In the absence of TEFM, POLRMT pauses at many sites leading to termination; TEFM suppresses this effect.","method":"Reconstituted in vitro transcription system with recombinant TEFM; processivity and transcript-length analysis; template-binding affinity assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — fully reconstituted in vitro system with recombinant protein, multiple functional readouts (processivity, termination at CSB II, template affinity), replicates and extends prior in vivo findings","pmids":["25690892"],"is_preprint":false},{"year":2018,"finding":"Single-molecule optical-tweezers assay revealed that TEFM enhances POLRMT transcription elongation by reducing the frequency of long-lived pauses and shortening their durations, without changing the pause-free elongation rate. TEFM also increases the stall force of POLRMT. At CSB II, TEFM modulates how POLRMT passes through this sequence, relevant to the switch between DNA replication and transcription.","method":"Single-molecule optical-tweezers transcription assay; real-time tracking of pause dynamics and stall force","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — single-molecule reconstituted assay with mechanistic resolution of pause dynamics; single lab but rigorous quantitative method","pmids":["30514634"],"is_preprint":false},{"year":2019,"finding":"Conditional Tefm knockout in mouse hearts is embryonically lethal and causes drastic reduction of promoter-distal mitochondrial transcripts; promoter-proximal transcripts increase but mostly terminate before the replication-transcription switch region, leading to profoundly reduced de novo mtDNA replication. Deep RNA sequencing of Tefm knockout tissue revealed accumulation of unprocessed mitochondrial transcripts, indicating TEFM also regulates mitochondrial RNA processing. BioID proximity-labeling showed TEFM interacts with multiple RNA processing factors in addition to POLRMT.","method":"Conditional knockout mouse model; deep RNA sequencing; BioID proximity labeling; mtDNA replication quantification","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional KO with defined phenotypic readouts plus BioID and deep sequencing, multiple orthogonal approaches","pmids":["31036713"],"is_preprint":false},{"year":2023,"finding":"Pathogenic TEFM variants in human patients cause reduced levels of promoter-distal mitochondrial RNA transcripts in muscle and primary fibroblasts, confirming that TEFM enhances POLRMT processivity in vivo. Tefm knockdown in zebrafish embryos produces neuromuscular junction abnormalities and abnormal mitochondrial function, establishing a genotype-phenotype correlation for TEFM loss of function.","method":"Patient-derived muscle and fibroblast RNA analysis; zebrafish tefm morpholino knockdown with NMJ and mitochondrial function readouts","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient cells plus zebrafish model with functional readouts, but mechanistic detail limited to transcript-level evidence from abstracts","pmids":["36823193"],"is_preprint":false},{"year":2025,"finding":"TEFM knockout in human cells decreases 7S DNA levels, strand-asynchronous replication intermediates, and mtDNA copy number, indicating that TEFM promotes the RNA-to-DNA transition at the H-strand replication origin (OH). Concurrently, tRNAs encoded near transcription promoters increase in TEFM knockout, indicating enhanced transcription initiation frequency. These data demonstrate that TEFM balances mitochondrial transcription and replication by facilitating transition from RNA synthesis to DNA synthesis at OH, in addition to conferring processivity to POLRMT.","method":"TEFM knockout cells; quantification of 7S DNA, replication intermediates, mtDNA copy number, and tRNA levels","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with multiple quantitative readouts in a single lab; novel mechanistic role proposed and supported but not yet independently replicated","pmids":["39922921"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures capture the mitochondrial transcription complex transitioning from open promoter complex to processive elongation complex through intermediate stages. These structures reveal the sequential disengagement of mtRNAP from TFAM and the promoter, release of TFB2M, and the recruitment of TEFM to the elongation complex, providing structural detail on how TEFM is incorporated into the transcription machinery.","method":"Cryo-EM structural determination of transcription complex intermediates","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — cryo-EM structures are high-quality mechanistic evidence but this is a preprint not yet peer-reviewed, and TEFM-specific functional validation is not described in the abstract","pmids":["bio_10.1101_2025.04.03.647028"],"is_preprint":true},{"year":2021,"finding":"In hepatocellular carcinoma cells, TEFM overexpression promotes ROS production and subsequent activation of ERK signaling; knockdown reduces these effects. TEFM co-localizes with mitochondria in LUAD cells and its absence disrupts mitochondrial transcripts and respiratory chain complex expression, causes mitochondrial membrane depolarization and elevated ROS leading to apoptosis.","method":"TEFM overexpression/knockdown in HCC and LUAD cell lines; ROS measurement; ERK pathway activity assays; JC-1 mitochondrial membrane potential staining; xenograft tumor models","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — cell-line overexpression/knockdown with phenotypic readouts but no direct biochemical mechanism established for ROS-ERK link; single lab, no orthogonal mechanistic validation","pmids":["33771980","39075464"],"is_preprint":false}],"current_model":"TEFM is a mitochondrial transcription elongation factor that directly binds the catalytic region of the mitochondrial RNA polymerase POLRMT, suppresses transcriptional pausing and premature termination (including at conserved sequence block II), dramatically enhances POLRMT processivity to produce genome-length transcripts, increases POLRMT affinity for elongation templates, regulates mitochondrial RNA processing through interactions with RNA processing factors, and facilitates the RNA-to-DNA transition at the H-strand replication origin to balance transcription with mtDNA replication."},"narrative":{"mechanistic_narrative":"TEFM is the mitochondrial transcription elongation factor that converts the mitochondrial RNA polymerase POLRMT from a distributive into a highly processive enzyme capable of producing genome-length transcripts [PMID:21278163, PMID:25690892]. It binds directly and RNase-resistantly to the catalytic region of POLRMT, and within mitochondria forms an RNA-dependent complex with nascent mitochondrial transcripts and processing factors including PTCD3 and DHX30; TEFM forms foci coincident with sites of newly synthesized mitochondrial RNA [PMID:21278163]. In a fully reconstituted system, TEFM increases POLRMT affinity for elongation-like DNA:RNA templates, suppresses pausing, and abolishes premature termination at conserved sequence block II (CSB II) [PMID:25690892]; single-molecule measurements localize this effect to a reduction in the frequency and duration of long-lived pauses and an increase in POLRMT stall force, with no change in the intrinsic elongation rate [PMID:30514634]. Beyond elongation, TEFM couples transcription to mtDNA maintenance: its loss collapses promoter-distal transcript synthesis, causes accumulation of unprocessed transcripts and recruitment of additional RNA processing factors, and impairs de novo mtDNA replication [PMID:31036713], while in human cells TEFM facilitates the RNA-to-DNA transition at the H-strand replication origin (OH), supporting 7S DNA formation, strand-asynchronous replication, and mtDNA copy number [PMID:39922921]. Pathogenic TEFM variants in patients reduce promoter-distal mitochondrial transcripts in muscle and fibroblasts, and tefm loss in zebrafish produces neuromuscular and mitochondrial defects, establishing TEFM loss of function as disease-causing [PMID:36823193].","teleology":[{"year":2011,"claim":"Established that human mitochondria require a dedicated elongation factor by identifying TEFM as a POLRMT-binding partner essential for synthesis of promoter-distal transcripts.","evidence":"RNAi knockdown with respiratory readout, mitochondrial affinity purification/Co-IP with RNase controls, deletion mapping, in vitro processivity assay, and live-cell imaging of RNA foci","pmids":["21278163"],"confidence":"High","gaps":["Did not define the precise pausing/termination sites suppressed by TEFM","Functional roles of co-purifying PTCD3 and DHX30 left unresolved"]},{"year":2015,"claim":"Demonstrated with purified components that TEFM alone is sufficient to confer processivity, suppress pausing, and block termination at CSB II, directly linking it to the replication-primer decision point.","evidence":"Fully reconstituted in vitro transcription system with recombinant TEFM; transcript-length, termination, and template-binding affinity assays","pmids":["25690892"],"confidence":"High","gaps":["Did not resolve the physical mechanism by which pauses are suppressed","In vitro CSB II behavior not yet connected to in vivo replication switching"]},{"year":2018,"claim":"Resolved the kinetic mechanism of TEFM action, showing it acts on pause dynamics and mechanical stability rather than the catalytic elongation rate.","evidence":"Single-molecule optical-tweezers transcription assay tracking pause frequency, pause duration, and stall force","pmids":["30514634"],"confidence":"High","gaps":["Structural basis of pause suppression not determined from kinetics alone","Single-lab measurement"]},{"year":2019,"claim":"Showed in vivo that TEFM is essential for development and couples elongation to both RNA processing and mtDNA replication, broadening its role beyond processivity.","evidence":"Conditional Tefm knockout mouse hearts, deep RNA sequencing, BioID proximity labeling, and mtDNA replication quantification","pmids":["31036713"],"confidence":"High","gaps":["Identities and direct roles of BioID-detected processing factors not validated","Mechanism linking elongation defect to replication failure not resolved at molecular level"]},{"year":2023,"claim":"Connected TEFM loss of function to human disease, confirming the in vivo requirement for TEFM in producing promoter-distal transcripts.","evidence":"Patient muscle and fibroblast RNA analysis plus zebrafish tefm morpholino knockdown with neuromuscular and mitochondrial readouts","pmids":["36823193"],"confidence":"Medium","gaps":["Mechanistic detail limited to transcript-level evidence","Variant-specific biochemical consequences not characterized"]},{"year":2025,"claim":"Defined a distinct role for TEFM in promoting the RNA-to-DNA transition at OH, positioning it as a balancer of transcription versus replication.","evidence":"Human TEFM knockout cells with quantification of 7S DNA, replication intermediates, mtDNA copy number, and promoter-proximal tRNA levels","pmids":["39922921"],"confidence":"Medium","gaps":["Not independently replicated","Molecular mechanism of the RNA-to-DNA handoff at OH not resolved"]},{"year":2025,"claim":"Provided structural snapshots of how TEFM is recruited as the mitochondrial transcription machinery transitions from initiation to processive elongation.","evidence":"Cryo-EM structures of transcription complex intermediates capturing TFAM/TFB2M release and TEFM recruitment (preprint)","pmids":["bio_10.1101_2025.04.03.647028"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","No TEFM-specific functional validation accompanying the structures"]},{"year":null,"claim":"How TEFM-dependent processivity, RNA processing regulation, and the OH RNA-to-DNA switch are mechanistically coordinated within a single elongation complex remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified molecular model linking pause suppression to replication-primer handoff","Direct roles of TEFM-associated RNA processing factors uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[3]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[5]}],"complexes":["mitochondrial transcription elongation complex"],"partners":["POLRMT","PTCD3","DHX30","TFAM","TFB2M"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96QE5","full_name":"Transcription elongation factor, mitochondrial","aliases":[],"length_aa":360,"mass_kda":41.7,"function":"Transcription elongation factor which increases mitochondrial RNA polymerase processivity (PubMed:21278163, PubMed:36823193). Regulates transcription of the mitochondrial genome, including genes important for the oxidative phosphorylation machinery (PubMed:21278163, PubMed:36823193)","subcellular_location":"Mitochondrion matrix; Mitochondrion matrix, mitochondrion nucleoid","url":"https://www.uniprot.org/uniprotkb/Q96QE5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TEFM","classification":"Common Essential","n_dependent_lines":590,"n_total_lines":1208,"dependency_fraction":0.48841059602649006},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DRG1","stoichiometry":0.2},{"gene":"KPNA4","stoichiometry":0.2},{"gene":"PSPC1","stoichiometry":0.2},{"gene":"PTMA","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"RPS16","stoichiometry":0.2},{"gene":"SRP9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TEFM","total_profiled":1310},"omim":[{"mim_id":"620451","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58; COXPD58","url":"https://www.omim.org/entry/620451"},{"mim_id":"616423","title":"DExH-BOX HELICASE 30; DHX30","url":"https://www.omim.org/entry/616423"},{"mim_id":"616422","title":"TRANSCRIPTION ELONGATION FACTOR, MITOCHONDRIAL; TEFM","url":"https://www.omim.org/entry/616422"},{"mim_id":"614918","title":"PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; PTCD3","url":"https://www.omim.org/entry/614918"},{"mim_id":"609060","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1","url":"https://www.omim.org/entry/609060"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TEFM"},"hgnc":{"alias_symbol":["FLJ22729"],"prev_symbol":["C17orf42"]},"alphafold":{"accession":"Q96QE5","domains":[{"cath_id":"1.10.150.280","chopping":"63-135","consensus_level":"high","plddt":90.7748,"start":63,"end":135},{"cath_id":"3.30.420.10","chopping":"150-356","consensus_level":"high","plddt":94.2583,"start":150,"end":356}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96QE5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96QE5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96QE5-F1-predicted_aligned_error_v6.png","plddt_mean":81.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TEFM","jax_strain_url":"https://www.jax.org/strain/search?query=TEFM"},"sequence":{"accession":"Q96QE5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96QE5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96QE5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96QE5"}},"corpus_meta":[{"pmid":"21278163","id":"PMC_21278163","title":"TEFM (c17orf42) is necessary for transcription of human mtDNA.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21278163","citation_count":145,"is_preprint":false},{"pmid":"25690892","id":"PMC_25690892","title":"TEFM is a potent stimulator of mitochondrial transcription elongation in vitro.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25690892","citation_count":89,"is_preprint":false},{"pmid":"31036713","id":"PMC_31036713","title":"TEFM regulates both transcription elongation and RNA processing in mitochondria.","date":"2019","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/31036713","citation_count":67,"is_preprint":false},{"pmid":"33771980","id":"PMC_33771980","title":"Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33771980","citation_count":25,"is_preprint":false},{"pmid":"36823193","id":"PMC_36823193","title":"TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36823193","citation_count":25,"is_preprint":false},{"pmid":"30514634","id":"PMC_30514634","title":"TEFM Enhances Transcription Elongation by Modifying mtRNAP Pausing Dynamics.","date":"2018","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/30514634","citation_count":12,"is_preprint":false},{"pmid":"39075464","id":"PMC_39075464","title":"Identification of TEFM as a potential therapeutic target for LUAD treatment.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39075464","citation_count":9,"is_preprint":false},{"pmid":"39719635","id":"PMC_39719635","title":"Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/39719635","citation_count":6,"is_preprint":false},{"pmid":"39731053","id":"PMC_39731053","title":"TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39731053","citation_count":2,"is_preprint":false},{"pmid":"39922921","id":"PMC_39922921","title":"TEFM facilitates transition from RNA synthesis to DNA synthesis at H-strand replication origin of mtDNA.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/39922921","citation_count":0,"is_preprint":false},{"pmid":"40272035","id":"PMC_40272035","title":"Clinical and Radiological Characterization of TEFM-Associated Neurological Disorder.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40272035","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.03.647028","title":"Structural Basis for Promoter Recognition and Transcription Factor Binding and Release in Human Mitochondria","date":"2025-04-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.03.647028","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7485,"output_tokens":2410,"usd":0.029302,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9615,"output_tokens":2699,"usd":0.057775,"stage2_stop_reason":"end_turn"},"total_usd":0.087077,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"TEFM is required for mitochondrial transcription elongation in human cells; RNAi knockdown causes respiratory incompetence and loss of promoter-distal mitochondrial transcripts from both H- and L-strands. Affinity purification from mitochondria shows TEFM forms a complex with POLRMT (mitochondrial RNA polymerase), mitochondrial transcripts, PTCD3, and DHX30; after RNase treatment only POLRMT remains associated with TEFM. TEFM interacts with the catalytic region of POLRMT (defined by deletion mutants). In vitro, TEFM enhances POLRMT processivity on ss- and dsDNA templates. TEFM contains two HhH motifs and an RNase H fold, similar to nuclear elongation factor Spt6. TEFM forms foci coincident with newly synthesized mitochondrial RNA in cultured cells.\",\n      \"method\": \"RNAi knockdown with respiratory phenotype readout; affinity purification/Co-IP from mitochondria; RNase treatment to define RNA-dependent vs. direct interactions; deletion mutagenesis to map POLRMT interaction; in vitro transcription processivity assay; live-cell imaging of foci\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (in vitro assay, Co-IP, deletion mutagenesis, live imaging, RNAi phenotype) in a single rigorous study establishing the core mechanism\",\n      \"pmids\": [\"21278163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Recombinant TEFM strongly stimulates POLRMT processivity in a fully reconstituted in vitro mitochondrial transcription system, dramatically increasing formation of longer transcripts. TEFM abolishes premature transcription termination at conserved sequence block II (CSB II), a site linked to replication primer formation. TEFM also substantially increases POLRMT affinity for an elongation-like DNA:RNA template. In the absence of TEFM, POLRMT pauses at many sites leading to termination; TEFM suppresses this effect.\",\n      \"method\": \"Reconstituted in vitro transcription system with recombinant TEFM; processivity and transcript-length analysis; template-binding affinity assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — fully reconstituted in vitro system with recombinant protein, multiple functional readouts (processivity, termination at CSB II, template affinity), replicates and extends prior in vivo findings\",\n      \"pmids\": [\"25690892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Single-molecule optical-tweezers assay revealed that TEFM enhances POLRMT transcription elongation by reducing the frequency of long-lived pauses and shortening their durations, without changing the pause-free elongation rate. TEFM also increases the stall force of POLRMT. At CSB II, TEFM modulates how POLRMT passes through this sequence, relevant to the switch between DNA replication and transcription.\",\n      \"method\": \"Single-molecule optical-tweezers transcription assay; real-time tracking of pause dynamics and stall force\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — single-molecule reconstituted assay with mechanistic resolution of pause dynamics; single lab but rigorous quantitative method\",\n      \"pmids\": [\"30514634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Conditional Tefm knockout in mouse hearts is embryonically lethal and causes drastic reduction of promoter-distal mitochondrial transcripts; promoter-proximal transcripts increase but mostly terminate before the replication-transcription switch region, leading to profoundly reduced de novo mtDNA replication. Deep RNA sequencing of Tefm knockout tissue revealed accumulation of unprocessed mitochondrial transcripts, indicating TEFM also regulates mitochondrial RNA processing. BioID proximity-labeling showed TEFM interacts with multiple RNA processing factors in addition to POLRMT.\",\n      \"method\": \"Conditional knockout mouse model; deep RNA sequencing; BioID proximity labeling; mtDNA replication quantification\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional KO with defined phenotypic readouts plus BioID and deep sequencing, multiple orthogonal approaches\",\n      \"pmids\": [\"31036713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Pathogenic TEFM variants in human patients cause reduced levels of promoter-distal mitochondrial RNA transcripts in muscle and primary fibroblasts, confirming that TEFM enhances POLRMT processivity in vivo. Tefm knockdown in zebrafish embryos produces neuromuscular junction abnormalities and abnormal mitochondrial function, establishing a genotype-phenotype correlation for TEFM loss of function.\",\n      \"method\": \"Patient-derived muscle and fibroblast RNA analysis; zebrafish tefm morpholino knockdown with NMJ and mitochondrial function readouts\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient cells plus zebrafish model with functional readouts, but mechanistic detail limited to transcript-level evidence from abstracts\",\n      \"pmids\": [\"36823193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TEFM knockout in human cells decreases 7S DNA levels, strand-asynchronous replication intermediates, and mtDNA copy number, indicating that TEFM promotes the RNA-to-DNA transition at the H-strand replication origin (OH). Concurrently, tRNAs encoded near transcription promoters increase in TEFM knockout, indicating enhanced transcription initiation frequency. These data demonstrate that TEFM balances mitochondrial transcription and replication by facilitating transition from RNA synthesis to DNA synthesis at OH, in addition to conferring processivity to POLRMT.\",\n      \"method\": \"TEFM knockout cells; quantification of 7S DNA, replication intermediates, mtDNA copy number, and tRNA levels\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with multiple quantitative readouts in a single lab; novel mechanistic role proposed and supported but not yet independently replicated\",\n      \"pmids\": [\"39922921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures capture the mitochondrial transcription complex transitioning from open promoter complex to processive elongation complex through intermediate stages. These structures reveal the sequential disengagement of mtRNAP from TFAM and the promoter, release of TFB2M, and the recruitment of TEFM to the elongation complex, providing structural detail on how TEFM is incorporated into the transcription machinery.\",\n      \"method\": \"Cryo-EM structural determination of transcription complex intermediates\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — cryo-EM structures are high-quality mechanistic evidence but this is a preprint not yet peer-reviewed, and TEFM-specific functional validation is not described in the abstract\",\n      \"pmids\": [\"bio_10.1101_2025.04.03.647028\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In hepatocellular carcinoma cells, TEFM overexpression promotes ROS production and subsequent activation of ERK signaling; knockdown reduces these effects. TEFM co-localizes with mitochondria in LUAD cells and its absence disrupts mitochondrial transcripts and respiratory chain complex expression, causes mitochondrial membrane depolarization and elevated ROS leading to apoptosis.\",\n      \"method\": \"TEFM overexpression/knockdown in HCC and LUAD cell lines; ROS measurement; ERK pathway activity assays; JC-1 mitochondrial membrane potential staining; xenograft tumor models\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — cell-line overexpression/knockdown with phenotypic readouts but no direct biochemical mechanism established for ROS-ERK link; single lab, no orthogonal mechanistic validation\",\n      \"pmids\": [\"33771980\", \"39075464\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TEFM is a mitochondrial transcription elongation factor that directly binds the catalytic region of the mitochondrial RNA polymerase POLRMT, suppresses transcriptional pausing and premature termination (including at conserved sequence block II), dramatically enhances POLRMT processivity to produce genome-length transcripts, increases POLRMT affinity for elongation templates, regulates mitochondrial RNA processing through interactions with RNA processing factors, and facilitates the RNA-to-DNA transition at the H-strand replication origin to balance transcription with mtDNA replication.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TEFM is the mitochondrial transcription elongation factor that converts the mitochondrial RNA polymerase POLRMT from a distributive into a highly processive enzyme capable of producing genome-length transcripts [#0, #1]. It binds directly and RNase-resistantly to the catalytic region of POLRMT, and within mitochondria forms an RNA-dependent complex with nascent mitochondrial transcripts and processing factors including PTCD3 and DHX30; TEFM forms foci coincident with sites of newly synthesized mitochondrial RNA [#0]. In a fully reconstituted system, TEFM increases POLRMT affinity for elongation-like DNA:RNA templates, suppresses pausing, and abolishes premature termination at conserved sequence block II (CSB II) [#1]; single-molecule measurements localize this effect to a reduction in the frequency and duration of long-lived pauses and an increase in POLRMT stall force, with no change in the intrinsic elongation rate [#2]. Beyond elongation, TEFM couples transcription to mtDNA maintenance: its loss collapses promoter-distal transcript synthesis, causes accumulation of unprocessed transcripts and recruitment of additional RNA processing factors, and impairs de novo mtDNA replication [#3], while in human cells TEFM facilitates the RNA-to-DNA transition at the H-strand replication origin (OH), supporting 7S DNA formation, strand-asynchronous replication, and mtDNA copy number [#5]. Pathogenic TEFM variants in patients reduce promoter-distal mitochondrial transcripts in muscle and fibroblasts, and tefm loss in zebrafish produces neuromuscular and mitochondrial defects, establishing TEFM loss of function as disease-causing [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established that human mitochondria require a dedicated elongation factor by identifying TEFM as a POLRMT-binding partner essential for synthesis of promoter-distal transcripts.\",\n      \"evidence\": \"RNAi knockdown with respiratory readout, mitochondrial affinity purification/Co-IP with RNase controls, deletion mapping, in vitro processivity assay, and live-cell imaging of RNA foci\",\n      \"pmids\": [\"21278163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the precise pausing/termination sites suppressed by TEFM\", \"Functional roles of co-purifying PTCD3 and DHX30 left unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated with purified components that TEFM alone is sufficient to confer processivity, suppress pausing, and block termination at CSB II, directly linking it to the replication-primer decision point.\",\n      \"evidence\": \"Fully reconstituted in vitro transcription system with recombinant TEFM; transcript-length, termination, and template-binding affinity assays\",\n      \"pmids\": [\"25690892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the physical mechanism by which pauses are suppressed\", \"In vitro CSB II behavior not yet connected to in vivo replication switching\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the kinetic mechanism of TEFM action, showing it acts on pause dynamics and mechanical stability rather than the catalytic elongation rate.\",\n      \"evidence\": \"Single-molecule optical-tweezers transcription assay tracking pause frequency, pause duration, and stall force\",\n      \"pmids\": [\"30514634\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of pause suppression not determined from kinetics alone\", \"Single-lab measurement\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed in vivo that TEFM is essential for development and couples elongation to both RNA processing and mtDNA replication, broadening its role beyond processivity.\",\n      \"evidence\": \"Conditional Tefm knockout mouse hearts, deep RNA sequencing, BioID proximity labeling, and mtDNA replication quantification\",\n      \"pmids\": [\"31036713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identities and direct roles of BioID-detected processing factors not validated\", \"Mechanism linking elongation defect to replication failure not resolved at molecular level\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected TEFM loss of function to human disease, confirming the in vivo requirement for TEFM in producing promoter-distal transcripts.\",\n      \"evidence\": \"Patient muscle and fibroblast RNA analysis plus zebrafish tefm morpholino knockdown with neuromuscular and mitochondrial readouts\",\n      \"pmids\": [\"36823193\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic detail limited to transcript-level evidence\", \"Variant-specific biochemical consequences not characterized\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined a distinct role for TEFM in promoting the RNA-to-DNA transition at OH, positioning it as a balancer of transcription versus replication.\",\n      \"evidence\": \"Human TEFM knockout cells with quantification of 7S DNA, replication intermediates, mtDNA copy number, and promoter-proximal tRNA levels\",\n      \"pmids\": [\"39922921\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Not independently replicated\", \"Molecular mechanism of the RNA-to-DNA handoff at OH not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided structural snapshots of how TEFM is recruited as the mitochondrial transcription machinery transitions from initiation to processive elongation.\",\n      \"evidence\": \"Cryo-EM structures of transcription complex intermediates capturing TFAM/TFB2M release and TEFM recruitment (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.04.03.647028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"No TEFM-specific functional validation accompanying the structures\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TEFM-dependent processivity, RNA processing regulation, and the OH RNA-to-DNA switch are mechanistically coordinated within a single elongation complex remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified molecular model linking pause suppression to replication-primer handoff\", \"Direct roles of TEFM-associated RNA processing factors uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\"mitochondrial transcription elongation complex\"],\n    \"partners\": [\"POLRMT\", \"PTCD3\", \"DHX30\", \"TFAM\", \"TFB2M\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}